Q4 2017 Holdings
Filed 2018-02-14 | 161 holdings | $305.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $142.0M | 445,607 | 46.5% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $43.7M | 489,745 | 14.3% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $33.5M | 346,313 | 11.0% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $14.6M | 114,966 | 4.8% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $9.4M | 85,804 | 3.1% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $9.0M | 310,250 | 3.0% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $8.9M | 272,400 | 2.9% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $7.4M | 245,885 | 2.4% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $6.6M | 264,600 | 2.1% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $6.2M | 935,368 | 2.0% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $5.6M | 265,045 | 1.8% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $4.2M | 639,370 | 1.4% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $2.9M | 46,466 | 1.0% |
| Cytokinetics, Inc.(CYTK) | Common | 23282W605 | $2.9M | 350,300 | 0.9% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $2.6M | 26,170 | 0.8% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | Common | 09058V103 | $2.2M | 449,255 | 0.7% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $869.0K | 203,935 | 0.3% |
| Coherus BioSciences, Inc.(CHRS) | Common | 19249H103 | $792.0K | 90,000 | 0.3% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $180.6K | 2,520,281 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $158.0K | 1,513,904 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $149.9K | 862,174 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $102.9K | 736,132 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $96.5K | 643,762 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $78.9K | 659,618 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $74.4K | 1,322,195 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $67.8K | 1,603,112 | 0.0% |
| UnitedHealth Group Inc.(UNH) | Class B | 91324P102 | $67.4K | 305,886 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $65.7K | 693,275 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $64.1K | 170,516 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $62.4K | 285,791 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $45.6K | 798,619 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $40.9K | 506,026 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $35.3K | 975,087 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $34.4K | 138,556 | 0.0% |
| Allergan plc | Shares | G0177J108 | $34.1K | 208,180 | 0.0% |
| Eli Lilly & Company(LLY) | Common | 532457108 | $32.4K | 383,099 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $32.1K | 381,882 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $31.3K | 201,739 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | Sponsored ADR | 881624209 | $30.0K | 1,583,108 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $26.6K | 366,521 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $26.2K | 137,968 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $25.2K | 325,067 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $23.2K | 230,158 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $21.4K | 349,121 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $20.7K | 132,352 | 0.0% |
| Cigna Corporation | Common | 125509109 | $20.3K | 100,002 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $19.3K | 123,950 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | S&P Biotech ETF | 78464A870 | $19.2K | 226,460 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $18.6K | 334,400 | 0.0% |
| Omega Healthcare Investors, Inc.(OHI) | Common | 681936100 | $16.0K | 579,785 | 0.0% |